Related Experiment Videos

Kinetics of immunologic responses after primary MMR vaccination

H F Pabst1, D W Spady, M M Carson

  • 1Department of Pediatrics, 2C3.00 Walter Mackenzie Centre, University of Alberta, Edmonton, Canada.

Vaccine
|January 1, 1997
PubMed

Insights

Measles vaccination in 12-month-olds induces a T-helper 1 (TH1) immune response, with plaque reduction neutralization (PRN) and blast transformation (BT) peaking at 30 days. Some temporary suppression of BT was observed post-vaccination.

Area of Science:

  • Immunology
  • Vaccinology

Background:

  • Measles vaccination is crucial for public health.
  • Understanding the immune response kinetics post-MMR vaccination is essential.

Purpose of the Study:

  • To investigate the temporal dynamics of humoral and cellular immunity following measles vaccination.
  • To assess for any transient immunosuppression associated with the MMR vaccine.

Main Methods:

  • Studied 124 children aged 12 months before and at multiple time points after MMR vaccination.
  • Measured plaque reduction neutralization (PRN) titers and assessed lymphocyte blast transformation (BT) responses.
  • Analyzed lymphocyte phenotypes, cytokine production (Interleukin 2, 4, 10, Interferon-gamma), and NK cell activity.

Main Results:

  • PRN titers and BT to measles hemagglutinin (HA) plateaued by 30 days post-vaccination.
  • CD8+ and NK cell populations increased post-immunization.
  • Mild suppression of BT was noted at 14 and 22 days; Interferon-gamma was the dominant cytokine, indicating a TH1 response.

Conclusions:

  • Primary measles immunization elicits a predominantly TH1-biased cellular immune response.
  • The MMR vaccine induces measurable changes in immune cell populations and function.
  • Transient immunosuppression of BT may occur early after vaccination.

Related Concept Videos